| 69 |
|
SCI(E)
|
2024
|
| 68 |
|
SCI(E)
|
2024
|
| 67 |
|
SCI(E)
|
2024
|
| 66 |
Design, synthesis of new 3H-imidazo[4,5-b]pyridine derivatives and evaluation of their inhibitory properties as mixed lineage kinase 3 inhibitors
|
SCI(E)
|
2024 |
| 65 |
Comparative Computational Analysis of Spike Protein Structural Stability in SARS-CoV-2 Omicron Subvariants
|
SCI(E)
|
2023 |
| 64 |
TWN-FS method: A novel fragment screening method for drug discovery |
SCI(E)
|
2023 |
| 63 |
ADis-QSAR: a machine learning model based on biological activity differences of compounds
|
SCI(E)
|
2023 |
| 62 |
TWN-RENCOD: A novel method for protein binding site comparison |
SCI(E)
|
2023
|
| 61 |
|
SCI(E)
|
2022 |
|
60
|
|
SCI(E)
|
2022
|
|
59
|
|
SCI(E)
|
2022
|
|
58
|
|
SCI(E)
|
2022
|
|
57
|
|
SCI(E)
|
2021
|
|
56
|
|
SCI(E)
|
2020
|
|
55
|
|
SCI(E)
|
2020
|
|
54
|
|
SCI(E)
|
2020
|
|
53
|
|
SCI(E)
|
2020
|
|
52
|
|
SCI(E)
|
2020
|
|
51
|
|
SCI(E)
|
2019
|
|
50
|
|
SCI(E)
|
2019
|
|
49
|
|
SCI(E)
|
2019
|
|
48
|
|
SCI(E)
|
2019
|
|
47
|
|
SCI(E)
|
2019
|
|
46
|
|
SCI(E)
|
2019
|
|
45
|
|
SCI(E)
|
2018
|
|
44
|
|
SCI(E)
|
2018
|
|
43
|
|
SCI(E)
|
2018
|
|
42
|
|
SCI(E)
|
2017
|
| 41 |
A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
|
SCI(E)
|
2017 |
| 40 |
Assessment of CCSD(T), MP2, and DFT methods for the calculations of structures and interaction energies of the peptide backbone with water molecules |
SCI(E)
|
2017 |
|
39
|
Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors |
SCI(E)
|
2017 |
|
38
|
|
SCI(E)
|
2017
|
|
37
|
|
SCI(E)
|
2016
|
|
36
|
|
SCI(E)
|
2016
|
|
35
|
|
SCI(E)
|
2016
|
|
34
|
|
SCI(E)
|
2016
|
|
33
|
|
SCI(E)
|
2016
|
|
32
|
|
SCI(E)
|
2016
|
| 31 |
Discovery of structural characteristics of RIP1K for activity control using the combination method |
SCI(E)
|
2015 |
| 30 |
Discovery of Tyk2 inhibitors via the virtual site-directed fragment-based drug design |
SCI(E)
|
2015 |
| 29 |
c-Met and ALK Inhibitory Constituents from Scutellaria baicalensis |
SCI(E)
|
2015 |
| 28 |
The discovery of bioisoster compound for plumbagin using the knowledge-based rational method |
SCI(E)
|
2014 |
| 27 |
The Discovery of Aurora Kinase Inhibitor by Multi-Docking-Based Virtual Screening |
SCI(E)
|
2014 |
| 26 |
Quantitative determination of enzalutamide, an anti-prostate cancer drug, in rat plasma using liquid chromatography-tandem mass spectrometry, and its application to a pharmacokinetic study |
SCI(E)
|
2014 |
| 25 |
Inhibition of STAT3 activation by KT-18618 via the disruption of the interaction between JAK3 and STAT3 |
SCI(E)
|
2014 |
| 24 |
Synthesis and anti-influenza virus activity of 4-oxo- orthioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-ones |
SCI(E)
|
2014 |
| 23 |
The analysis of water network for kinase selectivity based on the MD simulations |
SCI(E)
|
2014 |
| 22 |
Anti-diabetic and anti-inflammatory effect of a novel selective11β-HSD1 inhibitor in the diet-induced obese mice |
SCI(E)
|
2014 |
| 21 |
SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities |
SCI(E)
|
2013 |
| 20 |
Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects |
SCI(E)
|
2013 |
| 19 |
The discovery of inhibitors of Fas-mediated cell death pathway using the combined computational method |
SCI(E)
|
2013 |
| 18 |
Discovery of non-LBD inhibitor for androgen receptor by structure-guide design |
SCI(E)
|
2013 |
| 17 |
Analysis for Different Binding Modes of 11β-HSD1 Inhibitors in theHuman and Mouse Species by Developing Pharmacophore Models |
SCI(E)
|
2013 |
| 16 |
Cardiovascular effects of a novel selective Rho kinase inhibitor, 2-(1H-indazole-5-yl)amino-4-methoxy-6-piperazino triazine (DW1865). |
SCI(E)
|
2013 |
| 15 |
Characterization of Binding Mode for Human Coagulation Factor XI (FXI) Inhibitors |
SCI(E)
|
2013 |
| 14 |
KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer |
SCI(E)
|
2013 |
| 13 |
Identification of novel mPGES-1 inhibitors through screening of a chemical library |
SCI(E)
|
2012 |
| 12 |
Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice |
SCI(E)
|
2012 |
| 11 |
The Identification of Binding Mode for Arabidopsis thaliana 7-Keto-8-aminopelargonic Acid Synthase (AtKAPAS) Inhibitors |
SCI(E)
|
2012 |
| 10 |
Binding Free Energies of Inhibitors to Iron Porphyrin Complex as a Model for Cytochrome P450 |
SCI(E)
|
2012 |
| 9 |
Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives |
SCI(E)
|
2012 |
| 8 |
Cooperative Phosphorylation of FADD by Aur-A and Plk1 in Response to Taxol Triggers Both Apoptotic and Necrotic Cell Death |
SCI(E)
|
2011 |
| 7 |
A Novel 6-(2-methyl-2-alkylsubstituted-2H-chromen-6-yl)-amine Derivatives and Pharmacophore Model as 5-Lipoxygenase Inhibitors |
SCI(E)
|
2011 |
| 6 |
Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors |
SCI(E)
|
2011 |
| 5 |
A novel 3-arylethynyl-substituted pyrido[2,3,-b]pyrazine derivatives and pharmacophore model as Wnt2/b-catenin pathway inhibitors in non-small-cell lung cancer cell lines |
SCI(E)
|
2011 |
| 4 |
The Predictive QSAR Model for hERG Inhibitors Using Bayesian and Random Forest Classification Method |
SCI(E)
|
2011 |
| 3 |
Anti-diabetic and anti-adipogenic effects of a novel selective 11 beta-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344) |
SCI(E)
|
2011 |
| 2 |
Discovery of β-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors |
SCI(E)
|
2011 |
| 1 |
Discovery of new inhibitor for PDE3 by virtual screening |
SCI(E)
|
2011 |
